CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients? Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Effect of Aspirin on All-Cause Mortality in the Healthy Elderly Syncope After Percutaneous Coronary Intervention
|<<... 13 14 15 16 17 18 19 ...>>|

Review ArticleCirculation, 134 (5), 422-31

JOURNAL：Circulation. Article Link

Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention

AJ Kirtane, D Doshi, MB Leon et al. Keywords: angioplasty; coronary artery disease; coronary occlusion; heart failure; percutaneous coronary intervention

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top